A carregar...
Re-challenge chemotherapy with gemcitabine plus carboplatin in patients with non-small cell lung cancer
Despite recent improvements to current therapies and the emergence of novel agents to manage advanced non-small cell lung cancer (NSCLC), the patients' overall survival remains poor. Re-challenging with first-line chemotherapy upon relapse is common in the management of small cell lung cancer b...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Sun Yat-sen University Cancer Center
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3845541/ https://ncbi.nlm.nih.gov/pubmed/23981850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.013.10120 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|